Drag a card by its title · ⚙ to size, swap or remove

The company

Century Therapeutics, Inc.

IPSC · Nasdaq

Health CareBiotechnologyNot moving yetSynthetic Biology / TechBio

IPSC stood above a rising 150-day average in 32 of the last 52 weekly readings, and has been out of that trend for the last 13 weeks. It is 35.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 13
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $97K
Insider sales, 12 months: $154K
Officials’ trades on record: 0
Institutions holding: 95 (+27)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 32 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3

Sale orders, 12 months20

Buyers · sellers2 · 4

Who	Did	Shares	Traded
Douglas CarrSVP Finance & Operations	sold	1,658at $1.93	14 Sep 2026filed 15 Sep 2026
Gregory RussottiOfficer	sold	2,587at $1.93	14 Sep 2026filed 15 Sep 2026
Douglas CarrSVP Finance & Operations	sold	254at $2.05	8 Sep 2026filed 9 Sep 2026
Gregory RussottiOfficer	sold	534at $2.05	8 Sep 2026filed 9 Sep 2026
Douglas CarrSVP Finance & Operations	sold	275at $1.98	3 Aug 2026filed 5 Aug 2026
Douglas CarrSVP Finance & Operations	sold	1,654at $2.23	12 Jun 2026filed 15 Jun 2026
Gregory RussottiOfficer	sold	2,584at $2.23	12 Jun 2026filed 15 Jun 2026
Douglas CarrSVP Finance & Operations	sold	249at $2.11	8 Jun 2026filed 9 Jun 2026
Gregory RussottiOfficer	sold	524at $2.11	8 Jun 2026filed 9 Jun 2026
Douglas CarrSVP Finance & Operations	sold	264at $2.34	4 May 2026filed 6 May 2026
Douglas CarrSVP Finance & Operations	sold	7,043at $2.55	12 Mar 2026filed 16 Mar 2026
Gregory RussottiOfficer	sold	10,076at $2.55	12 Mar 2026filed 16 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders95+27 on the quarter

New · exited36 · 9

Reported value$387.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026	17,754,430$43.5M	00.0%
TCG Crossover Management, LLCunchanged · filed 14 Aug 2026	17,754,430$43.4M	00.0%
Versant Venture Management, LLCunchanged · filed 12 Aug 2026	12,166,109$29.8M	00.0%
Deep Track Capital, LPreduced · filed 14 Aug 2026	9,462,645$23.2M	-25,100−0.3%
RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026	8,695,652$21.3M	00.0%
Venrock Adviser, LLCunchanged · filed 14 Aug 2026	8,695,652$21.3M	00.0%
Commodore Capital LPunchanged · filed 14 Aug 2026	8,695,652$21.3M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	8,091,768$19.8M	+6,567,346+430.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	5,703,680$14.0M	+17,476+0.3%
Balyasny Asset Management L.P.added · filed 14 Aug 2026	5,522,944$13.5M	+505,211+10.1%